GSK-Valneva end legacy vaccines partnership
GSK and Valneva have come to a mutual early termination agreement, as the former looks to ‘allocate capital to fewer, highest priority areas’.
Archives for June 25, 2019
Emergent in $535m smallpox contract with US government
Emergent to supply a treatment for complications of smallpox vaccination to the Strategic National Stockpile, under $535m contract with the HHS.
Global vaccine market expected to develop into $48bn sector
The global vaccines market will develop at a rate of 6% through to 2025, driven by national need for immunization programs and expansion into different therapeutic areas.
‘Miniaturized’ vaccine production line to be adapted for M&R program
After a grant from the Bill & Melinda Gates Foundation, Univercells will adapt its low-footprint, cabinet-contained vaccine production line to create affordable measles and rubella vaccinations.
Does the anti-vaxx movement impact vaccine production rates?
As the US faces a measles outbreak, and bills removing rights to exempt from vaccination are debated, vaccine manufacturers stress the need to educate the public.
WuXi Biologics adds ADC commercial manufacturing at WuXi city facility
WuXi Biologics expands its biologics conjugation solution center to include space for commercial manufacturing of antibody-drug conjugates for the biopharma industry.
Cell therapies reordering the CDMO market, says Thermo Fisher
Thermo Fisher has moved from ‘selling services’ to ‘selling solutions’, adapting to the demands of cell and gene therapies, executive says.
Purigen raises $26M to commercialize biological sample prep platform
Purigen Biosystems has raised funds to support the commercialization of its automated nucleic acid sample preparation platform.